JP2023538265A5 - - Google Patents
Info
- Publication number
- JP2023538265A5 JP2023538265A5 JP2023507735A JP2023507735A JP2023538265A5 JP 2023538265 A5 JP2023538265 A5 JP 2023538265A5 JP 2023507735 A JP2023507735 A JP 2023507735A JP 2023507735 A JP2023507735 A JP 2023507735A JP 2023538265 A5 JP2023538265 A5 JP 2023538265A5
- Authority
- JP
- Japan
- Prior art keywords
- mass
- formulation
- approximately
- amount
- basic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063060843P | 2020-08-04 | 2020-08-04 | |
| US202063060856P | 2020-08-04 | 2020-08-04 | |
| US63/060,843 | 2020-08-04 | ||
| US63/060,856 | 2020-08-04 | ||
| PCT/US2021/044381 WO2022031729A1 (en) | 2020-08-04 | 2021-08-03 | Formulations of phosphoinositide 3-kinase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023538265A JP2023538265A (ja) | 2023-09-07 |
| JP2023538265A5 true JP2023538265A5 (https=) | 2024-08-13 |
Family
ID=77519798
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023507735A Pending JP2023538265A (ja) | 2020-08-04 | 2021-08-03 | ホスホイノシチド３－キナーゼ阻害剤の製剤 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20220040193A1 (https=) |
| EP (1) | EP4192431A1 (https=) |
| JP (1) | JP2023538265A (https=) |
| CA (1) | CA3187759A1 (https=) |
| TW (1) | TWI886312B (https=) |
| WO (1) | WO2022031729A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20210124310A (ko) | 2019-02-06 | 2021-10-14 | 벤테라, 인코포레이티드 | 국소 포스포이노시티드 3-키나제 억제제 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100774855B1 (ko) * | 2000-04-27 | 2007-11-08 | 아스텔라스세이야쿠 가부시키가이샤 | 축합 헤테로아릴 유도체 |
| US6608053B2 (en) | 2000-04-27 | 2003-08-19 | Yamanouchi Pharmaceutical Co., Ltd. | Fused heteroaryl derivatives |
| US6468989B1 (en) | 2000-07-13 | 2002-10-22 | Dow Pharmaceutical Sciences | Gel compositions containing metronidazole |
| US6387383B1 (en) | 2000-08-03 | 2002-05-14 | Dow Pharmaceutical Sciences | Topical low-viscosity gel composition |
| GB0423653D0 (en) * | 2004-10-25 | 2004-11-24 | Piramed Ltd | Pharmaceutical compounds |
| CN102268014B (zh) * | 2010-06-03 | 2015-06-03 | 上海艾力斯医药科技有限公司 | 一类稠合杂芳基衍生物、制备方法及其应用 |
| GB201011771D0 (en) * | 2010-07-13 | 2010-08-25 | Bioinvent Int Ab | Biological material and particular uses thereof |
| BR112013008615B1 (pt) * | 2010-10-13 | 2021-05-11 | Medivir Ab | composição farmacêutica |
| US20170340649A1 (en) * | 2016-05-30 | 2017-11-30 | Sun Pharmaceutical Industries Limited | Topical aqueous spray compositions of halobetasol |
| KR102358377B1 (ko) * | 2016-12-28 | 2022-02-03 | 히사미쓰 세이야꾸 가부시키가이샤 | 첩부제 |
| KR20210124310A (ko) * | 2019-02-06 | 2021-10-14 | 벤테라, 인코포레이티드 | 국소 포스포이노시티드 3-키나제 억제제 |
-
2021
- 2021-08-03 EP EP21762225.7A patent/EP4192431A1/en active Pending
- 2021-08-03 US US17/393,196 patent/US20220040193A1/en not_active Abandoned
- 2021-08-03 JP JP2023507735A patent/JP2023538265A/ja active Pending
- 2021-08-03 WO PCT/US2021/044381 patent/WO2022031729A1/en not_active Ceased
- 2021-08-03 CA CA3187759A patent/CA3187759A1/en active Pending
- 2021-08-04 TW TW110128732A patent/TWI886312B/zh active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5461068A (en) | Imidazole derivative tincture and method of manufacture | |
| US6740326B1 (en) | Topical nail care compositions | |
| ZA200602046B (en) | Transdermal pharmaceutical formulation for minimizing skin residues | |
| AU3989199A (en) | Topical compositions for prostaglandin E1 delivery | |
| CZ285679B6 (cs) | Farmaceutický a kosmetický prostředek k místnímu nanášení na pokožku a způsob jeho přípravy | |
| KR20030060769A (ko) | 프로스타글란딘 ｅ₁을 함유하는 국소 조성물 | |
| CA2352915C (en) | Pharmaceutical compositions containing mupirocin | |
| JP2001513093A (ja) | 局所用ニムスリドゲルシステム | |
| JPH0645542B2 (ja) | イミダゾ−ル−エタノ−ルエステル | |
| JP2023538265A5 (https=) | ||
| US20190083492A1 (en) | Topical minoxidil composition | |
| JPH11349451A (ja) | 育毛剤 | |
| JPH07116035B2 (ja) | 被膜形成性抗真菌剤組成物 | |
| AU2007311607A1 (en) | Pharmaceutical compositions and nasal spray incorporating anhydrous mometasone furoate | |
| KR100457850B1 (ko) | 활성 물질의 방출성이 큰 겔형 항진균성 약제학적 제제 | |
| JPS6218526B2 (https=) | ||
| WO2016157112A1 (en) | Topical spray compositions of mometasone furoate | |
| ES2523934T3 (es) | Derivados novedosos de guanidinas de la serie cinámica | |
| US20200129495A1 (en) | Ebastine topical composition | |
| JPS59184125A (ja) | 抗糸状菌剤 | |
| US5879711A (en) | Stable antiandrogenic gel composition | |
| TWI916963B (zh) | 外用組合物及其製造方法與用途 | |
| TW202606699A (zh) | 包含米諾地爾之外用劑組成物 | |
| EP0367586B1 (en) | Primycin solutions | |
| JPH0383926A (ja) | 軟膏組成物 |